Sahin Boydas
Random theme
Select theme
Back to all articles

Why AI Diagnostic Tools Fail in Hospitals

After more than ten years in Silicon Valley, I’ve seen a lot of changes. AI in healthcare is one of the biggest shifts, and I want to share the lessons I’ve learned from my own startups and investments—what worked, what didn’t, and the surprises along the way.

2024-03-207 min read593 words

After more than ten years in Silicon Valley, I’ve seen a lot of changes. AI in healthcare is one of the biggest shifts, and I want to share the lessons I’ve learned from my own startups and investments—what worked, what didn’t, and the surprises along the way.

The Framework That Actually Works

Here is a simple framework for evaluating AI diagnostics. It's not complicated, but it requires discipline.

Step 1: you need to move fast and break things

This is where most people go wrong. They skip this step entirely and jump straight to execution. Don't do that.

Step 2: most founders overthink this and underspend on execution

Once you have the foundation right, this becomes much easier. I've watched founders struggle with this for months when the answer was staring them in the face.

Step 3: Iterate relentlessly

Nothing works perfectly the first time. The companies that get AI diagnostics right treat it as an ongoing process, not a one-time project.

The Reality Nobody Talks About

A lot of the advice on AI diagnostics rests on assumptions that made sense five years ago. The world has moved on.

The first thing to understand is that your team matters more than your technology. I've seen this play out across dozens of companies. The pattern is unmistakable.

Many teams spend months on the wrong path before realizing that timing is everything in this game. Once they make the switch, everything changes.

What I Tell Founders

Before deciding anything about AI diagnostics, start with three questions:

1

What's your timeline? Because the right approach for a company with 6 months of runway is very different from one with 3 years.

2

What have you already tried? Most founders have tried something. Understanding what didn't work is often more valuable than knowing what might.

3

Who on your team owns this? If the answer is "everyone" or "no one," that's your first problem to solve.

These questions seem simple but they reveal a lot about where a company actually stands.

This connects to broader themes around healthcare automation, clinical AI, biotech AI, medical AI that I've been thinking about a lot lately.

What's Next

Best practice in AI diagnostics is changing fast. What worked last year might not work next year. That's both the challenge and the opportunity.

My advice: stay curious, stay humble, and stay close to the people who are actually doing the work. Read less thought leadership and do more experiments. Talk to fewer consultants and more practitioners.

If you're building in this space, the best time to get AI diagnostics right is before you need to. Don't wait for a crisis to force your hand.

I'll keep sharing what I learn. This stuff matters too much to keep to myself.

FAQ

Frequently Asked Questions

Q:How long did it take to see results?

Most meaningful business results take 3-6 months to materialize. Anyone promising overnight success is selling something. The companies in my portfolio that grew fastest were the ones that stayed patient and consistent.

Q:What was the biggest challenge in this case?

Almost always, the biggest challenge is people and alignment, not technology or strategy. Getting the right team focused on the right problem is harder than any technical challenge I've encountered.

Q:Can these results be replicated?

The specific numbers will vary, but the underlying patterns and principles are transferable. The key is understanding the context behind the results, not just copying the tactics. Every company has unique constraints that shape what works.

Written by

Sahin Boydas

Serial entrepreneur, #1 angel investor, author of Becoming Top 1%

Get Sahin's Weekly Insights

Join 10,000+ founders and investors. One email per week with actionable advice on startups, investing, and building in the AI era.

No spam. Unsubscribe anytime.